Publications

Find at Harvard

July 2025
Case

The Future in Sight: LumineticsCore and the First Autonomous AI for Diagnostics

By: Michael Lingzhi Li and Tinglong Dai

After two decades of research, Dr. Michael Abramoff successfully launched LumineticsCore—the first autonomous AI system authorized by the FDA to diagnose diabetic retinopathy without physician oversight. The case traces his journey across algorithm design, clinical... View Details

Keywords: Healthcare; AI; Regulation; Medical Technology; Health Care and Treatment; AI and Machine Learning; Medical Specialties; Health Industry; Health Industry; United States

Educators

2019
White Paper

Impact-Weighted Financial Accounts: The Missing Piece for an Impact Economy

By: George Serafeim, T. Robert Zochowski and Jennifer Downing

Reimagining capitalism is an imperative. We need to create a more inclusive and sustainable form of capitalism that works for every person and the planet. Massive environmental damage, growing income and wealth disparity, stress, and depression within developed... View Details

Keywords: Impact-Weighted Accounts; IWAI; Background; Economic Systems; Economy; Corporate Social Responsibility and Impact; Measurement and Metrics; Financial Statements

28 Nov 2011
Research & Ideas

Rethinking the Fairness of Organ Transplants

system to provide good matches so patients survive longer, but with fairness. By contrast, rather than designing a policy and then looking at what the outcomes are, Trichakis and his coauthors allow policymakers to start with desired... View Details

Keywords: by Dennis Fisher; Health

2018
Working Paper

How Scheduling Can Bias Quality Assessment: Evidence from Food Safety Inspections

By: Maria Ibanez and Michael W. Toffel

Many production processes are subject to inspection to ensure they meet quality, safety, and environmental standards imposed by companies and regulators. Inspection accuracy is critical to inspections being a useful input to assessing risks, allocating quality... View Details

Keywords: Assessment; Bias; Inspection; Scheduling; Econometric Analysis; Empirical Research; Regulation; Health; Food; Safety; Quality; Performance Consistency; Performance Evaluation; Food and Beverage Industry; Service Industry

SSRN

30 Mar 2010
First Look

First Look: March 30

outcomes salient (Burns & Corpus, 2004), the bias did not emerge when the presentation did not draw attention to recent outcomes. Fixing Health Care on the Front Lines Author:Richard M.J. Bohmer... View Details

Keywords: Sean Silverthorne

July–September 2023
Article

A Systematic Review of Respect Between Acute Care Nurses and Physicians

By: Derrick P. Bransby, Anna T. Mayo, Matthew A. Cronin, Katie Park and Christina Yuan

Background: Interprofessional collaboration between nurses and physicians has become an essential part of patient care, which, when lacking, can lead to well-known challenges. One possible explanation for ineffective nurse–physician collaboration is a lack of... View Details

Keywords: Relationships; Status and Position; Cooperation; Attitudes; Behavior; Outcome or Result; Health Industry

August 2008 (Revised September 2008)
Case

The Flaxil Label (A)

This case focuses on the 2001 negotiation between Mytex Pharmaceuticals and the U.S. Food and Drug Administration (FDA). The outcome of the negotiation would determine the new label for Mytex's blockbuster drug for arthritis, Flaxil. The negotiation is quite... View Details

Keywords: Governing Rules, Regulations, and Reforms; Health Disorders; Product Launch; Negotiation Process; Business and Government Relations; Safety; Pharmaceutical Industry

Educators

May 2016
Article

How the Affordable Care Act Has Affected Cancer Care in the United States: Has Value for Cancer Patients Improved?

By: Stephen M. Schleicher, Nancy M. Wood, Seohyun Lee and Thomas W. Feeley

The Patient Protection and Affordable Care Act (ACA), passed in 2010, contained a number of provisions with potential to directly or indirectly affect cancer care. Value for patients was widely discussed throughout the bill, and the Centers for Medicare and Medicaid... View Details

Keywords: Value; Laws and Statutes; Health Care and Treatment; Health Industry; United States

November 2022
Case

Ajax Health: A New Model for Medical Technology Innovation

By: Regina E. Herzlinger and Ben Creo

This case teaches key success factors for both startup and established MedTech firms. It examines how to structure a firm to maximize innovation and financial returns with organizational structures that better align the incentives for the different skill sets... View Details

Keywords: Business Startups; Success; Innovation Strategy; Mergers and Acquisitions; Market Entry and Exit; Financial Strategy; Business Model; Partners and Partnerships; Entrepreneurship; Private Equity; Technology Industry; Medical Devices and Supplies Industry

Educators

May 21, 2020
Editorial

Primary Care Is Hurting: Why Aren't Private Insurers Pitching In?

By: Leemore S. Dafny and J. Michael McWilliams

Primary care clinicians are the front line for patients with suspected infection. We rely on them to diagnose, triage, and manage patients with potential or confirmed COVID infections. They are also responsible for keeping non-COVID medical conditions under control... View Details

Keywords: COVID-19; Primary Care; Health Pandemics; Health Care and Treatment; Financial Condition; Insurance

20 Nov 2018
First Look

New Research and Ideas, November 20, 2018

Outcome measures top the list, with 60% of respondents saying they are extremely important. This survey suggests that many in health care see value-based reimbursement as a real solution to the nation’s... View Details

Keywords: Dina Gerdeman

July 2019
Article

The Impact of Price Regulation on the Availability of New Drugs in Germany

By: Ariel Dora Stern, Felicitas Pietrulla, Annika Herr, Aaron S. Kesselheim and Ameet Sarpatwari

The 2011 German Pharmaceutical Market Restructuring Act (“AMNOG”) subjected branded, non-rare disease drugs to price regulation based on an assessment of their clinical benefit. Assessment outcomes range from “major added benefit” to “less benefit than the appropriate... View Details

Keywords: Regulation; Pharmaceuticals; Healthcare; Health Care and Treatment; Price; Governing Rules, Regulations, and Reforms; Pharmaceutical Industry; Germany

Find at Harvard

24 Jan 2017
First Look

First Look at New Research: January 24, 2017

care. The paper contains an interview with Kaplan and Porter about their experiences with improving the measurement of health care outcomes and cost. Publisher's link:... View Details

Keywords: Sean Silverthorne

09 Aug 2016
First Look

August 9, 2016

that covers 1992–2008 and many states. We describe differences in the types of businesses initially formed by immigrants and their medium-term growth patterns. We also consider the relationship of these outcomes to the immigrants’ age at... View Details

Keywords: Sean Silverthorne

January 2024
Article

Cost of Exempting Sole Orphan Drugs from Medicare Negotiation

By: Matthew Vogel, Olivia Zhao, William B. Feldman, Amitabh Chandra, Aaron S. Kesselheim and Benjamin N. Rome

Importance: The Inflation Reduction Act (IRA) requires Medicare to negotiate prices for some high-spending drugs but exempts drugs approved solely for the treatment of a single rare disease.
Objective: To estimate Medicare spending and global... View Details

Keywords: Health Care and Treatment; Insurance; Price; Health Industry

Find at Harvard

Article

Comparative Costs of Advanced Proton and Photon Radiation Therapies: Lessons from Time-driven Activity-based Costing in Head and Neck Cancer

By: Nikhil G. Thaker, Steven J. Frank and Thomas W. Feeley

Time-driven activity-based costing (TDABC) is an innovative costing tool in healthcare that can be used to directly compare the true cost of competing technologies over the full care cycle. Rather than only comparing therapeutic effectiveness over a limited number of... View Details

Keywords: Head And Neck Cancer; IMRT; Proton Therapy; Time-Driven ABC; Information Technology; Activity Based Costing and Management; Medical Specialties